scholarly article | Q13442814 |
P50 | author | Sunil Kapila | Q59650596 |
P2093 | author name string | William V Giannobile | |
Paul J Kostenuik | |||
Chan Ho Park | |||
Matthew D Dunn | |||
P2860 | cites work | Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats | Q72158392 |
Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats | Q72182070 | ||
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption | Q73995291 | ||
Localization of receptor activator of NFkappaB ligand, RANKL, in periodontal tissues during experimental movement of rat molars | Q74603360 | ||
Anchorage provided during intra-arch distal molar movement: a comparison between the Nance appliance and a fixed frontal bite plane | Q81754604 | ||
Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro | Q83960033 | ||
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 | ||
Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading | Q31129878 | ||
Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength | Q31157658 | ||
Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption | Q34263153 | ||
Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection | Q35008871 | ||
Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength | Q36269835 | ||
Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper | Q36355771 | ||
Bisphosphonate-associated osteonecrosis of the jaws: a review of current knowledge | Q36355774 | ||
Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. | Q36968967 | ||
Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling | Q40252553 | ||
Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells | Q40410296 | ||
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3. | Q41687961 | ||
Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement | Q42823302 | ||
The effect of a single dose of osteoprotegerin in postmenopausal women | Q43520860 | ||
Osteoclast recruitment to sites of compression in orthodontic tooth movement | Q43800198 | ||
Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis | Q43866531 | ||
Involvement of nitric oxide in orthodontic tooth movement in rats | Q44134051 | ||
Effect of misoprostol, a prostaglandin E1 analog, on orthodontic tooth movement in rats | Q44221384 | ||
A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases | Q44291815 | ||
The effect of prostaglandin E2 and calcium gluconate on orthodontic tooth movement and root resorption in rats | Q44434028 | ||
Effects of echistatin and an RGD peptide on orthodontic tooth movement | Q44562197 | ||
Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement | Q44562200 | ||
Tissue reaction to orthodontic tooth movement in acute and chronic corticosteroid treatment | Q44780129 | ||
Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. | Q44785758 | ||
Local RANKL gene transfer to the periodontal tissue accelerates orthodontic tooth movement | Q45854964 | ||
Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice | Q45874107 | ||
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women | Q46133598 | ||
Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis | Q46425033 | ||
Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. | Q46699294 | ||
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice | Q47776871 | ||
Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. | Q51220391 | ||
The effects of exogenous prostaglandins on orthodontic tooth movement in rats. | Q51593567 | ||
Regulation of synthesis of osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand in normal human osteoblasts via the p38 mitogen-activated protein kinase pathway by the application of cyclic tensile strain. | Q54646116 | ||
The effect of age on tooth movement and mineral density in the alveolar tissues of the rat | Q68520408 | ||
Measuring dental drift and orthodontic tooth movement in response to various initial forces in adult rats | Q70149250 | ||
The effect of force magnitude on extractable bone resorptive activity and cemental cratering in orthodontic tooth movement | Q72040557 | ||
P433 | issue | 3 | |
P304 | page(s) | 446-455 | |
P577 | publication date | 2007-05-08 | |
P1433 | published in | Bone | Q15755003 |
P1476 | title | Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement | |
P478 | volume | 41 |
Q64093490 | A Novel Analysis via Micro-CT Imaging Indicates That Chemically Modified Tetracycline-3 (CMT-3) Inhibits Tooth Relapse after Orthodontic Movement: A Pilot Experimental Study |
Q34253400 | A Novel Rat Model of Orthodontic Tooth Movement Using Temporary Skeletal Anchorage Devices: 3D Finite Element Analysis and In Vivo Validation |
Q51374518 | A mechanobiological model of orthodontic tooth movement. |
Q37177844 | Bis-enoxacin inhibits bone resorption and orthodontic tooth movement |
Q97653029 | Comparative assessment of mouse models for experimental orthodontic tooth movement |
Q37286024 | Differential patterns of receptor activator of nuclear factor kappa B ligand/osteoprotegerin expression in human periapical granulomas: possible association with progressive or stable nature of the lesions. |
Q28538339 | Domain of dentine sialoprotein mediates proliferation and differentiation of human periodontal ligament stem cells |
Q33896735 | Effect of age on regulation of human osteoclast differentiation |
Q35622970 | Effect of bisphosphonates on orthodontic tooth movement-an update |
Q43817444 | Effect of triiodothyronine on the maxilla and masseter muscles of the rat stomatognathic system. |
Q45859090 | Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth |
Q54592047 | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis |
Q45251196 | Effects of probiotic therapy on metabolic and inflammatory parameters of rats with ligature-induced periodontitis associated with restraint stress |
Q38631395 | Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review |
Q34950408 | Force-induced Adrb2 in periodontal ligament cells promotes tooth movement |
Q39786822 | Immobilized-OPG-Fc on a titanium surface inhibits RANKL-dependent osteoclast differentiation in vitro. |
Q38425187 | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability |
Q38414010 | Locally limited inhibition of bone resorption and orthodontic relapse by recombinant osteoprotegerin protein. |
Q40783444 | M1-like Macrophage Polarization Promotes Orthodontic Tooth Movement |
Q59136070 | Macrophages mediate corticotomy-accelerated orthodontic tooth movement |
Q52613205 | Microsphere controlled drug delivery for local control of tooth movement. |
Q37889113 | New perspectives on osteogenesis imperfecta |
Q44215606 | Orthodontic force increases interleukin-1β and tumor necrosis factor-α expression and alveolar bone loss in periodontitis. |
Q34127948 | Osteoclasts and odontoclasts: signaling pathways to development and disease |
Q41459925 | Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression. |
Q53295176 | Osteoprotegerin and zoledronate bone effects during orthodontic tooth movement. |
Q37510285 | Pathways in external apical root resorption associated with orthodontia. |
Q46377336 | Plasma rich in growth factors had limited effect on early bone formation in extraction sockets: Response to "Anitua, E., Alkhraisat, M.H. & Orive, G. (2013) Letter to the Editor: Rigorous methodology is the school of coherent conclusions in science. |
Q47215322 | RANK/RANKL/OPG Expression in Rapid Maxillary Expansion. |
Q53372188 | Recombinant osteoprotegerin effects during orthodontic movement in a rat model. |
Q34950251 | Selective β2-adrenergic Antagonist Butoxamine Reduces Orthodontic Tooth Movement. |
Q92946483 | Single Local Injection of Epigallocatechin Gallate-Modified Gelatin Attenuates Bone Resorption and Orthodontic Tooth Movement in Mice |
Q97538091 | Tensile force-induced PDGF-BB/PDGFRβ signals in periodontal ligament fibroblasts activate JAK2/STAT3 for orthodontic tooth movement |
Q37629885 | The Potential Use of Pharmacological Agents to Modulate Orthodontic Tooth Movement (OTM). |
Q37461270 | The effect of antioxidants on the production of pro-inflammatory cytokines and orthodontic tooth movement |
Q33713098 | Tooth Movement After Infrared Laser Phototherapy: Clinical Study in Rodents |
Q58778474 | Transcriptional activation of glucose transporter 1 in orthodontic tooth movement-associated mechanical response |
Search more.